Seattle Genetics Inc (NASDAQ:SGEN)

48.78
Delayed Data
As of 4:00pm ET
 -1.02 / -2.05%
Today’s Change
45.31
Today|||52-Week Range
71.32
-8.82%
Year-to-Date
No recent news for Seattle Genetics Inc.

Today’s Trading

Previous close49.80
Today’s open49.89
Day’s range48.61 - 50.49
Volume911,319
Average volume (3 months)1,077,713
Market cap$9.0B
Data as of 4:00pm ET, 04/24/2018

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)-78.71%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+15.33%
P/E ratioNM
Price/Sales15.88
Price/Book12.19

Competitors

 Today’s
change
Today’s
% change
TSROTESARO Inc+1.04+2.00%
ALKSAlkermes Plc-0.81-1.79%
ALNYAlnylam Pharmaceutic...-1.13-1.18%
IONSIonis Pharmaceutical...-5.37-10.59%
Data as of 4:00pm ET, 04/24/2018

Financials

Next reporting dateApril 27, 2018
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$482.3M
Annual profit (last year)-$125.5M
Net profit margin-26.03%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
CFO &
Principal Accounting Officer
Todd E. Simpson
Corporate headquarters
Bothell, Washington

Forecasts